The COVID-19 pandemic

M Ciotti, M Ciccozzi, A Terrinoni, WC Jiang… - Critical reviews in …, 2020 - Taylor & Francis
In December 2019, an outbreak of pneumonia of unknown origin was reported in Wuhan,
Hubei Province, China. Pneumonia cases were epidemiologically linked to the Huanan …

Covid-19 image data collection: Prospective predictions are the future

JP Cohen, P Morrison, L Dao, K Roth… - arXiv preprint arXiv …, 2020 - arxiv.org
Across the world's coronavirus disease 2019 (COVID-19) hot spots, the need to streamline
patient diagnosis and management has become more pressing than ever. As one of the …

[HTML][HTML] COVID-19 in ESRD and acute kidney injury

JP Kooman, FM van der Sande - Blood purification, 2021 - karger.com
The COVID-19 pandemic has greatly affected nephrology. Firstly, dialysis patients appear to
be at increased risk for infection due to viral transmission next to an enhanced risk for …

No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial

H Jamaati, SMR Hashemian, B Farzanegan… - European journal of …, 2021 - Elsevier
The aim of this study was to evaluate the clinical effects of dexamethasone administration in
patients with mild to moderate acute respiratory distress syndrome (ARDS) due to …

Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial

F Dastan, A Saffaei, S Haseli, M Marjani… - International …, 2020 - Elsevier
Background The clinical presentation of SARS-CoV-2 infection ranges from mild symptoms
to severe complications, including acute respiratory distress syndrome. In this syndrome …

SARS-CoV-2 and viral sepsis: immune dysfunction and implications in kidney failure

A Stasi, G Castellano, E Ranieri, B Infante… - Journal of clinical …, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of
coronavirus disease 2019 (COVID-19), first emerged in Wuhan, China. The clinical …

The early start of hemoperfusion decreases the mortality rate among severe COVID‐19 patients: A preliminary study

H Mikaeili, A Taghizadieh, M Nazemiyeh… - Hemodialysis …, 2022 - Wiley Online Library
Abstract Background Coronavirus disease‐2019 (COVID‐19)‐related organ failure is partly
related to a sepsis‐like syndrome and extreme pro‐inflammatory cytokine release, named …

The efficacy of resin hemoperfusion cartridge on inflammatory responses during adult cardiopulmonary bypass

Z He, H Lu, X Jian, G Li, D Xiao, Q Meng, J Chen… - Blood …, 2022 - karger.com
Aim: This study aimed to evaluate the efficacy of the resin hemoperfusion device (HA380
hemoperfusion cartridge) on inflammatory responses during adult cardiopulmonary bypass …

Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID‐19 (SARS‐CoV‐2) disease: a …

RS Mousavi‐Roknabadi, F Haddad… - Journal of medical …, 2021 - Wiley Online Library
Some previous studies suggested that the plasma exchange (PE) and hemoperfusion (HP)
played a cardinal role in the treatment of severe coronavirus disease 2019 (COVID‐19) …

The role of artificial cells in the fight against COVID-19: deliver vaccine, hemoperfusion removes toxic cytokines, nanobiotherapeutics lower free radicals and pCO2 …

TMS Chang - Artificial Cells, Nanomedicine, and Biotechnology, 2022 - Taylor & Francis
This review concentrates on how artificial cells can contribute to helping patients with COVID-
19. Artificial cells have led to mRNA vaccines with more improvements to come. Excessive …